로그인시 본인확인과정이 필요할 수 있습니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기
| 국가/구분 | United States(US) Patent 등록 |
|---|---|
| 국제특허분류(IPC7판) |
|
| 출원번호 | US-0813699 (2015-07-30) |
| 등록번호 | US-9669160 (2017-06-06) |
| 발명자 / 주소 |
|
| 출원인 / 주소 |
|
| 대리인 / 주소 |
|
| 인용정보 | 피인용 횟수 : 0 인용 특허 : 249 |
A portable infusion pump can communicate with continuous glucose monitor (CGM) to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin.
A portable infusion pump can communicate with continuous glucose monitor (CGM) to receive continuous feedback relating to a user's blood glucose level during insulin or other medicament therapy and can automatically deliver insulin to a user when the CGM data indicates a need for additional insulin. Because patient behavior can interfere with the accuracy and efficacy of such closed loop or semi-closed loop therapy, a system can employ various mechanisms for manual temporary suspension of closed-loop therapy when a patient is aware that current or future behavior may inhibit therapy.
1. An infusion pump system, comprising: a delivery mechanism adapted to facilitate delivery of medicament to a patient;memory adapted to store parameters relating to the delivery of medicament;a communications device adapted to receive information from a continuous glucose monitor; anda processor fu
1. An infusion pump system, comprising: a delivery mechanism adapted to facilitate delivery of medicament to a patient;memory adapted to store parameters relating to the delivery of medicament;a communications device adapted to receive information from a continuous glucose monitor; anda processor functionally linked to the delivery mechanism and the memory and to the communications device to obtain the information from the continuous glucose monitor, the processor configured to: cause the delivery mechanism to deliver medicament to the patient according to therapy parameters determined based on the information from the continuous glucose monitor;determine from user-defined input that the patient is going to take or has taken a medication;suspend delivery of medicament according to the determined therapy parameters for a suspension period in response to the determination that the patient is going to take or has taken a medication;cause the delivery mechanism to deliver medicament according to a default medicament delivery schedule stored in memory during the suspension period; andresume causing the delivery mechanism to deliver medicament to the patient according to the determined therapy parameters following the suspension period, andwherein the processor is further configured to receive a duration for the suspension period entered through a user interface in communication with the processor. 2. The portable infusion pump of claim 1, wherein the processor is further configured to receive an indication of a type of medication the patient is going to take or has taken. 3. The portable infusion pump of claim 2, wherein the processor is further configured to determine whether the type of medication is one likely to cause the information from the continuous glucose monitor to become unreliable, and suspend delivery of the medicament only if the type of medication is one likely to cause the information from the continuous glucose monitor to become unreliable. 4. The portable infusion pump of claim 1, wherein the processor is configured to resume causing the delivery mechanism to deliver medicament to the patient according to the determined therapy parameters automatically following the suspension period. 5. The portable infusion pump of claim 1, wherein the processor is further configured to provide a prompt on the user interface in communication with the processor that the suspension period has ended and to resume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters following the suspension period only after receiving a confirmation in response to the prompt. 6. The portable infusion pump of claim 1, wherein the processor is configured to determine the therapy parameters based on the information from the continuous glucose monitor. 7. An infusion pump system, comprising: a delivery mechanism adapted to facilitate a delivery of a medicament to a patient;a memory adapted to store parameters relating to the delivery of the medicament;a communications device adapted to receive information from a continuous glucose monitor; anda processor functionally linked to the delivery mechanism and the memory and to the communications device to obtain the information from the continuous glucose monitor, the processor configured to: cause the delivery mechanism to deliver the medicament to the patient according to therapy parameters determined based on the information from the continuous glucose monitor;determine from user-defined input that the patient is going to take or has taken a medication;suspend delivery of the medicament according to the determined therapy parameters for a suspension period in response to the determination that the patient is going to take or has taken a medication;cause the delivery mechanism to deliver the medicament according to a default medicament delivery schedule stored in the memory during the suspension period; andresume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters following the suspension period, andwherein the processor is further configured to receive an indication of the type of the medication the patient is going to take or has taken and determine a duration for the suspension period based on the type of the medication. 8. The portable infusion pump of claim 7, wherein the processor additionally determines the duration for the suspension period based at least in part on a dosage size of the medication. 9. The portable infusion pump of claim 7, wherein the processor is further configured to determine whether the type of the medication is on likely to cause the information from the continuous glucose monitor to become unreliable, and suspend delivery of the medicament only if the type of the medication is one likely to cause the information from the continuous glucose monitor to become unreliable. 10. The portable infusion pump of claim 7, wherein the processor is configured to resume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters automatically following the suspension period. 11. The portable infusion pump of claim 7, wherein the processor is further configured to provide a prompt a user interface in communication with the processor that suspension period has ended and to resume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters following the suspension period only after receiving a confirmation in response to the prompt. 12. The portable infusion pump of claim 7, wherein the processor is configured to determine the therapy parameters based on the information from the continuous glucose monitor. 13. An infusion pump system, comprising: a delivery mechanism adapted to facilitate a delivery of a medicament to a patient;a memory adapted to store parameters relating to the delivery of the medicament;a communications device adapted to receive information from a continuous glucose monitor; anda processor functionally linked to the delivery mechanism and the memory and to the communications device to obtain the information from the continuous glucose monitor, the processor configured to: cause the delivery mechanism to deliver the medicament to the patient according to therapy parameters determined based on the information from the continuous glucose monitor;receive an indication that the patient is going to take or has taken a medication;suspend delivery of the medicament according to the determined therapy parameters for a suspension period in response to the indication;cause the delivery mechanism to deliver the medicament according to a default medicament delivery schedule stored in the memory during the suspension period; andresume causing the delivery mechanism to deliver the medicament to the patient according to the determine therapy parameters following the suspension period,wherein the processor is further configured to receive an indication of a type of medication the patient is going to take or has taken, andwherein the processor is further configured to determine whether the type of medication is one likely to cause the information from the continuous glucose monitor to become unreliable, and suspend delivery of the medicament only if the type of medication is one likely to cause the information from the continuous glucose monitor to become unreliable. 14. The portable infusion pump of claim 13, wherein the processor is further configured to receive a duration for the suspension period entered through a user interface in communication with the processor. 15. The portable infusion pump of claim 13, wherein the processor is further configured to determine a duration for the suspension period based on the type of medication. 16. The portable infusion pump of claim 15, wherein, the processor additionally determines the duration for the suspension period based at least in part on a dosage size of the medication. 17. The portable infusion pump of claim 13, wherein the processor is configured to resume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters automatically following the suspension period. 18. The portable infusion pump of claim 13, wherein the processor is further configured to provide a prompt on a user interface in communication with the processor that the suspension period has ended and to resume causing the delivery mechanism to deliver the medicament to the patient according to the determined therapy parameters following the suspension period only after receiving a confirmation in the response to the prompt. 19. The portable infusion pump of claim 13, wherein the processor is configured to determine the therapy parameters based on the information from the continuous glucose monitor.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.